YILI(600887)2023-04-27 16:00Financial Performance - The company achieved a net profit of ¥9,529,007,857.85 for the year 2022, with a total distributable profit of ¥20,193,062,014.56 after accounting for retained earnings[3]. - The company's operating revenue for 2022 was approximately ¥122.70 billion, an increase of 11.40% compared to ¥110.14 billion in 2021[13]. - Net profit attributable to shareholders for 2022 was approximately ¥9.43 billion, reflecting an 8.34% increase from ¥8.70 billion in 2021[13]. - The company achieved total revenue of CNY 123.171 billion, a year-on-year increase of 11.37%, and a net profit of CNY 9.318 billion, up 6.71% from the previous year[28]. - The company reported a net profit margin of approximately 8.8% for 2022, slightly down from 9.3% in 2021[194]. - The total revenue for the year was 6,439.2356 million CNY, with no change in shareholding for the board members[87]. - The company reported a total comprehensive income of ¥9,462,126,281.23 for 2022, up from ¥8,376,267,735.75 in 2021[198]. Dividends and Share Capital - A cash dividend of ¥10.40 per 10 shares (including tax) is proposed, amounting to a total of ¥6,631,374,785.36, which represents 70.31% of the net profit attributable to shareholders[3]. - The total cash dividend amount (including tax) is 6,934,493,429.94 RMB, which accounts for 73.53% of the net profit attributable to ordinary shareholders in the consolidated financial statements[107]. - The total share capital as of March 31, 2023, is 6,398,918,718 shares, after deducting 22,596,809 shares held in the repurchase account[3]. - The company maintained a consistent shareholding of 472,027,056 shares throughout the year[87]. - The company repurchased and canceled 785,600 restricted shares as part of the 2019 stock incentive plan, resulting in a total share capital of 6,399,345,318 shares[160]. Assets and Liabilities - The total assets at the end of 2022 reached approximately ¥130.97 billion, marking a significant increase of 28.44% from ¥101.96 billion at the end of 2021[13]. - Total liabilities increased to CNY 76.82 billion in 2022, up from CNY 53.17 billion in 2021, representing a growth of 44.4%[191]. - The company's total equity attributable to shareholders reached CNY 50.27 billion in 2022, up from CNY 47.71 billion in 2021, indicating a growth of 5.3%[191]. - The company's goodwill increased significantly to CNY 4.95 billion from CNY 306.29 million, indicating a substantial investment in acquisitions[190]. - The company's debt-to-asset ratio increased to 58.66%, up 12.48% from 52.15% in 2021[183]. Cash Flow - The net cash flow from operating activities decreased by 13.57% to approximately ¥13.42 billion, down from ¥15.53 billion in 2021[13]. - The cash inflow from operating activities was approximately ¥137.82 billion, an increase of 10.9% from ¥124.25 billion in 2021[199]. - The cash outflow for investment activities surged to approximately ¥21.00 billion, compared to ¥8.18 billion in the previous year, indicating a rise of 156.5%[200]. - The net cash flow from investment activities was negative at approximately -¥19.51 billion, worsening from -¥7.80 billion in 2021[200]. Research and Development - The company’s R&D expenses increased by 36.69% to CNY 821.55 million, up from CNY 601.02 million in the previous year[36]. - The company is focused on enhancing its innovation capabilities, having received 76 domestic and international technology innovation awards during the reporting period[31]. - Research and development expenses increased to ¥646,093,606.80, compared to ¥543,192,049.39 in the previous year, reflecting a focus on innovation[198]. Market Position and Growth - The company's liquid dairy product retail market share is 33.4%, maintaining the leading position in the segment[22]. - The company’s overseas business revenue grew by 52.2% compared to 2021, reflecting successful international expansion[25]. - The company has seen a 20% increase in high-growth businesses such as organic dairy and plant-based nutrition products compared to 2021[24]. - The company is focusing on expanding its market presence and enhancing product development strategies to drive future growth[188]. Governance and Compliance - The company has established a clear governance structure to protect the rights of all shareholders, particularly minority shareholders[81]. - The company strictly adheres to information disclosure regulations, ensuring that all shareholders have equal access to information[83]. - The company has not reported any changes in shareholding among its directors and supervisors during the reporting period[87]. - The company has implemented a comprehensive internal control system, enhancing management efficiency and ensuring compliance with legal regulations[111]. Environmental and Social Responsibility - The company invested a total of CNY 203.91 million in environmental protection facilities in 2022, focusing on wastewater treatment facility upgrades and online monitoring equipment[124]. - The company achieved a reduction of 21,000 tons of sludge in 2022 by converting 27 wastewater treatment systems to a biological membrane method, with 25 systems achieving zero sludge operation[130]. - The company has committed to sustainable development and green management, continuously upgrading its green initiatives and actions[136]. - The company donated a total of 10,484.49 million RMB in cash and materials in response to major disaster events during the reporting period[143]. Future Outlook - The company plans to achieve a total revenue of 135.5 billion RMB and a total profit of 12.5 billion RMB in 2023, subject to market uncertainties[78]. - The company aims to invest 8.73 billion RMB in leading industry projects and supporting projects in 2023, with funding sourced from self-raised funds, bank loans, and other financing methods[79]. - Future strategies include expanding production capacity and enhancing product quality through technological advancements[120].